TARIFFS LATEST

US, China to slash tariffs for 90 days

NYSE American - Delayed Quote USD

Know Labs, Inc. (KNW)

0.4550

-0.0080

(-1.73%)

At close: May 9 at 4:00:00 PM EDT

0.4480

-0.01

(-1.54%)

Pre-Market: 7:13:25 AM EDT

Know Labs Sensor Non-Invasively Identifies pH Levels in Real Time

SEATTLE, March 19, 2025--Know Labs, Inc. (NYSE American: KNW) is pleased to announce that it has completed extensive research in its laboratory utilizing its patented Radio Frequency Dielectric Spectroscopy (RFDS) sensor technology to identify changes in pH levels in real time. The research has been submitted for peer reviewed publication. The research is available for review today here on the Company’s website at www.knowlabs.co.

Business Wire last month

KNW
-1.73%
Know Labs to Attend the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

SEATTLE, March 18, 2025--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology with its Radio Frequency Dialectic Spectroscopy (RFDS) platform, today announced the company will be attending The 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) Technology Fair in Amsterdam, Netherlands on March 19-22, 2025.

Business Wire last month

KNW
-1.73%
Know Labs, Inc. to Report First Quarter FY 2025 Results

SEATTLE, February 14, 2025--Know Labs, Inc. (previously NYSE American: KNW, now OTC Markets: KNWN), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS) for non-invasive medical diagnostic technology and diverse other fields of use through its newly initiated Know Labs Technology Licensing (KTL) initiative, today reported financial results for the first quarter of the fiscal year 2025.

Business Wire 2 months ago

KNWN
Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2025 Results on February 14, 2025

SEATTLE, February 13, 2025--Know Labs, Inc. (previously NYSE American: KNW, now OTC Markets: KNWN), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS) for non-invasive medical diagnostic technology and diverse other fields of use through its newly initiated Know Labs Technology Licensing (KTL) initiative, today announced it will host a webcast to review business updates and results for its first quarter of the fiscal year 2025 ended on Decemb

Business Wire 2 months ago

KNWN
Know Labs Technology Licensing (KTL) Announces Formalized Client Engagement

SEATTLE, February 06, 2025--Know Labs, Inc. (OTC: KNWN) is pleased to announce the official launch of its structured client engagement process for Know Labs Technology Licensing (KTL), ensuring a seamless pathway for corporations, universities, and research institutions to integrate and innovate with KTL’s patented Radio Frequency Dielectric Spectroscopy (RFDS) technology, products and services.

Business Wire 3 months ago

KNWN
Know Labs Files Appeal to NYSE Commencement of Proceedings to Delist

SEATTLE, February 05, 2025--Know Labs, Inc. (previously NYSE American: KNW, now OTC Markets: KNWN), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS), announced today it has filed an appeal of the NYSE American’s commencement of proceedings to delist Know Labs from its exchange. The Company will continue working on certain curative actions to regain compliance to maintain its listing while it awaits its appeal to the Listings Qualifications

Business Wire 3 months ago

KNWN
Know Labs Responds to NYSE Commencement of Proceedings to Delist

SEATTLE, January 30, 2025--Know Labs, Inc. (NYSE American: KNW), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS), announced today it is working on certain curative actions to regain compliance to maintain its listing and appeal the NYSE's determination to delist its common stock to the Listings Qualifications Panel of the Exchange. The company's stock will be suspended from trading on the NYSE American during this time. NYSE Regulation is

Business Wire 3 months ago

KNW
-1.73%
Know Labs Launches Know Labs Technology Licensing (KTL)

SEATTLE, January 21, 2025--Know Labs, Inc. (NYSE American: KNW), a pioneering leader in the development and application of radio frequency dielectric spectroscopy (RFDS), is proud to announce the formation of its new business unit, Know Labs Technology Licensing, (KTL). Modeled after the successful Qualcomm Technology Licensing (QTL) framework, KTL will be dedicated to licensing Know Labs’ robust intellectual property (IP) portfolio to corporate partners, academic institutions and research organ

Business Wire 3 months ago

KNW
-1.73%
Know Labs, Inc. Announces $300K Registered Direct Offering

SEATTLE, December 13, 2024--Know Labs, Inc. Announces $300K Registered Direct Offering

Business Wire 4 months ago

KNW
-1.73%
Know Labs, Inc. Announces NYSE American Acceptance of Plan to Regain Compliance

SEATTLE, December 11, 2024--Know Labs, Inc. Announces NYSE American Acceptance of Plan to Regain Compliance with the listing standards.

Business Wire 4 months ago

KNW
-1.73%
Know Labs Provides Overview of FY2024 10-K Annual Report

SEATTLE, November 18, 2024--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive diagnostics technology released this morning an overview of its Form 10-K annual report for its fiscal year ending September 30, 2024, and provided reassurance regarding its progress over the past year, its plans and the state of its financial stability in light of its auditor required going concern opinion.

Business Wire 5 months ago

KNW
-1.73%
Know Labs, Inc. Announces Receipt of Audit Opinion with Going Concern Explanation

SEATTLE, November 16, 2024--Know Labs, Inc. (NYSE American: KNW), leading developer of non-invasive diagnostics technology, today announced that, as previously disclosed in its Annual Report on Form 10-K for the year ended September 30, 2024, which was filed on November 14, 2024 with the Securities and Exchange Commission, the audited financial statements contained an audit opinion from its independent registered public accounting firm that included an explanatory paragraph related to the Compan

Business Wire 5 months ago

KNW
-1.73%
Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2024 Results

SEATTLE, November 15, 2024--Know Labs, an emerging developer of non-invasive medical diagnostic technology, reported financial results for the Q4 and fiscal year of 2024.

Business Wire 5 months ago

KNW
-1.73%
Know Labs Announces Expanded Technology Leadership in its Executive Team

SEATTLE, October 22, 2024--Know Labs Announces Expanded Technology Leadership in its Executive Team; Acceleration of Platform Development to Secure Strategic Partnerships

Business Wire 6 months ago

KNW
-1.73%
Know Labs Sensor Technology in Steering Wheels Could Curb Impaired Driving

SEATTLE, October 16, 2024--Know Labs Sensor Technology in Steering Wheels Could Curb Impaired Driving. Know Labs Retains Stanbridge Group to Secure Automotive JV Partnerships

Business Wire 6 months ago

KNW
-1.73%
Know Labs Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards

SEATTLE, October 02, 2024--Know Labs Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards. A Plan for Compliance has been undertaken

Business Wire 7 months ago

KNW
-1.73%
Know Labs Study Published in IEEE Sensors Journal

SEATTLE, September 10, 2024--Peer-reviewed journal publication validates Know Labs’ proprietary technology and its application for non-invasive blood glucose monitoring.

Business Wire 7 months ago

KNW
-1.73%
Know Labs, Inc. Announces $1.655 Million Public Offering

SEATTLE, August 16, 2024--Know Labs, Inc. (NYSE American: KNW) (the "Company"), a leading developer of non-invasive medical diagnostic technology, today announced that it has entered into definitive agreements with certain investors to purchase 6,365,385 Units for an aggregate offering of $1.655 million at a public offering price of $0.26 per unit, with each unit consisting of one share of its common stock and one warrant to purchase one share of its common stock at an initial exercise price of

Business Wire 8 months ago

KNW
-1.73%
Know Labs, Inc. Reports Third Quarter FY 2024 Results

SEATTLE, August 14, 2024--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostic technology, today reported financial results for the third quarter of the fiscal year 2024 ended June 30, 2024.

Business Wire 8 months ago

KNW
-1.73%
Know Labs, Inc. Announces Closing of $3.445 Million Public Offering

SEATTLE, August 12, 2024--Know Labs, Inc. (NYSE American: KNW), a leading developer of non-invasive medical diagnostics technology, today announced the successful closing of its previously announced underwritten public offering of 13,250,000 units at a public offering price of $0.26 per unit, with each unit consisting of one share of its common stock and one warrant to purchase one share of its common stock at an initial exercise price of $0.26, and the partial exercise of the underwriters’ opti

Business Wire 8 months ago

KNW
-1.73%

Performance Overview

Return	KNW	S&P 500 (^GSPC)
YTD	+167.65%	-3.77%
1-Year	-24.17%	+8.55%
3-Year	-71.20%	+41.81%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

TARIFFS LATEST

Know Labs, Inc. (KNW)

Know Labs Sensor Non-Invasively Identifies pH Levels in Real Time

Know Labs to Attend the 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

Know Labs, Inc. to Report First Quarter FY 2025 Results

Know Labs, Inc. to Host Review of First Quarter Fiscal Year 2025 Results on February 14, 2025

Know Labs Technology Licensing (KTL) Announces Formalized Client Engagement

Know Labs Files Appeal to NYSE Commencement of Proceedings to Delist

Know Labs Responds to NYSE Commencement of Proceedings to Delist

Know Labs Launches Know Labs Technology Licensing (KTL)

Know Labs, Inc. Announces $300K Registered Direct Offering

Know Labs, Inc. Announces NYSE American Acceptance of Plan to Regain Compliance

Know Labs Provides Overview of FY2024 10-K Annual Report

Know Labs, Inc. Announces Receipt of Audit Opinion with Going Concern Explanation

Know Labs, Inc. Reports Fourth Quarter and Fiscal Year 2024 Results

Know Labs Announces Expanded Technology Leadership in its Executive Team

Know Labs Sensor Technology in Steering Wheels Could Curb Impaired Driving

Know Labs Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards

Know Labs Study Published in IEEE Sensors Journal

Know Labs, Inc. Announces $1.655 Million Public Offering

Know Labs, Inc. Reports Third Quarter FY 2024 Results

Know Labs, Inc. Announces Closing of $3.445 Million Public Offering

Performance Overview